CONSENSUS STATEMENT
AdMeTech convened a Consensus Conference in 2009, which brought together over 40 leaders of medicine, government, industry, and advocacy and concluded the following:            

“We firmly believe that more accurate imaging technology would lead to better patient care, including guidance for diagnosis, biopsy and minimally-invasive therapy. Real and important improvements in prostate cancer care are at hand if we are resolved to increase the national investment in prostate diagnostics.”

EMERGING SCIENTIFIC EVIDENCE
Current data indicate that imaging technologies may detect prostate cancer missed with current diagnostics, including biopsy.

• MRI detects early, small cancer (red) in the prostate (green) before it spreads to the surrounding organs.
• Advanced MRI can now make it possible to provide precisely targeted, minimally-invasive guidance for biopsy and removal of cancer.

EXPECTED IMPACT
In the same way that mammography transformed breast cancer care, advanced prostate cancer imaging will:

• Save lives;
• Improve early diagnosis, which is critical for cure;
• Enable the least invasive and the most effective care;
• Decrease treatment complications and discomfort;
• Eliminate unnecessary procedures;
• Improve quality of life in millions of men;
• Reduce health care costs by at least $5 billion annually...read more